Global Neglected Tropical Disease (NTD) Treatment Market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 3.2 billion by 2030 from USD 2.1 billion in 2018. The market is driven by factors such as increasing prevalence of NTDs, rising awareness about NTDs and their treatment, and growing investments in research and development activities for the treatment of NTDs.
The global neglected tropical disease (NTD) treatment market is segmented on the basis of type into drugs and vaccines; application into hospitals and clinics, diagnostic centers, academic and research organizations; region into North America, Latin America, Europe, Asia Pacific & Middle East & Africa; forecast period 2021-2030.
On the basis of type: Drugs accounted for more than 50% share in 2018 owing to their ease of administration as compared to vaccines which require multiple doses over a long duration for complete protection against diseases like malaria or dengue fever. Vaccines are expected to grow at a CAGR of 6% during the forecast period owing to increasing demand from emerging markets such as China where there are high incidences of diseases like malaria or dengue fever that can be prevented with vaccination against these diseases On the basis of application: Hospitals & clinics accounted for more than 50% share in 2018 due to higher incidence rates among patients who seek medical care at hospitals or clinics with better access to healthcare facilities than those who live in remote areas without access to healthcare facilities or have limited resources available for self-treatment at home due lack financial means or education levels required for self-treatment at home with drugs prescribed by doctors/medical practitioners/healthcare providers etc, Diagnostic centers accounted for less than 10% share in 2018 due mainly because they provide services only when patients come seeking diagnosis rather than providing preventive services through vaccination programs etc, Academic & research organizations accounted for less than 10% share in 2018 because they focus on conducting research rather than providing preventive services through vaccination programs etc, On the basis between regions: North America dominated this market accounting more than 40% share followed by Europe accounting more then 30%.
Some Of The Growth Factors Of This Market:
- The World Health Organization (WHO) estimates that there are over 1 billion people in the world who are infected with at least one NTD.
- The WHO also estimates that there are over 2 billion people in the world who live in areas where they are at risk of contracting an NTD.
- There is a lack of awareness about the existence and prevalence of NTDs, which leads to a lack of funding for research and development into treatments for these diseases, as well as a lack of funding for prevention programs to reduce transmission rates.
- There is also a lack of access to treatment due to high costs and limited availability, which leads to increased mortality rates from these diseases among those who do not have access to treatment or prevention programs.
- In addition, many countries do not have adequate health care systems or infrastructure necessary for diagnosis and treatment.
Industry Growth Insights published a new data on “Neglected Tropical Disease (NTD) Treatment Market”. The research report is titled “Neglected Tropical Disease (NTD) Treatment Market research by Types (Drugs, Vaccines), By Applications (Hospitals and Clinics, Diagnostic Centers, Academic and Research Organizations), By Players/Companies F. Hoffmann-La Roche, Bayer, GlaxoSmithKline, Novartis, Pfizer, Eisai, Sanofi, Astellas Pharma, Takeda Pharmaceutical Company, Gilead Sciences”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Neglected Tropical Disease (NTD) Treatment Market Research Report
By Type
Drugs, Vaccines
By Application
Hospitals and Clinics, Diagnostic Centers, Academic and Research Organizations
By Companies
F. Hoffmann-La Roche, Bayer, GlaxoSmithKline, Novartis, Pfizer, Eisai, Sanofi, Astellas Pharma, Takeda Pharmaceutical Company, Gilead Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
 Treatment Industry Outlook.svg)
Global Neglected Tropical Disease (NTD) Treatment Market Report Segments:
The global Neglected Tropical Disease (NTD) Treatment market is segmented on the basis of:
Types
Drugs, Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Diagnostic Centers, Academic and Research Organizations
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- F. Hoffmann-La Roche
- Bayer
- GlaxoSmithKline
- Novartis
- Pfizer
- Eisai
- Sanofi
- Astellas Pharma
- Takeda Pharmaceutical Company
- Gilead Sciences
 Treatment Market Overview.svg)
Highlights of The Neglected Tropical Disease (NTD) Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drugs
- Vaccines
- By Application:
- Hospitals and Clinics
- Diagnostic Centers
- Academic and Research Organizations
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neglected Tropical Disease (NTD) Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Treatment Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for NTDs will vary depending on the specific condition. However, some common treatments include antibiotics and vaccines.
Some of the major players in the neglected tropical disease (ntd) treatment market are F. Hoffmann-La Roche, Bayer, GlaxoSmithKline, Novartis, Pfizer, Eisai, Sanofi, Astellas Pharma, Takeda Pharmaceutical Company, Gilead Sciences.
The neglected tropical disease (ntd) treatment market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Neglected Tropical Disease (NTD) Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Neglected Tropical Disease (NTD) Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Neglected Tropical Disease (NTD) Treatment Market - Supply Chain
4.5. Global Neglected Tropical Disease (NTD) Treatment Market Forecast
4.5.1. Neglected Tropical Disease (NTD) Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Neglected Tropical Disease (NTD) Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Neglected Tropical Disease (NTD) Treatment Market Absolute $ Opportunity
5. Global Neglected Tropical Disease (NTD) Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Type
5.3.1. Drugs
5.3.2. Vaccines
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Neglected Tropical Disease (NTD) Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Application
6.3.1. Hospitals and Clinics
6.3.2. Diagnostic Centers
6.3.3. Academic and Research Organizations
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Neglected Tropical Disease (NTD) Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Neglected Tropical Disease (NTD) Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Neglected Tropical Disease (NTD) Treatment Demand Share Forecast, 2019-2026
9. North America Neglected Tropical Disease (NTD) Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Application
9.4.1. Hospitals and Clinics
9.4.2. Diagnostic Centers
9.4.3. Academic and Research Organizations
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Type
9.7.1. Drugs
9.7.2. Vaccines
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Neglected Tropical Disease (NTD) Treatment Demand Share Forecast, 2019-2026
10. Latin America Neglected Tropical Disease (NTD) Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Application
10.4.1. Hospitals and Clinics
10.4.2. Diagnostic Centers
10.4.3. Academic and Research Organizations
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Type
10.7.1. Drugs
10.7.2. Vaccines
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Neglected Tropical Disease (NTD) Treatment Demand Share Forecast, 2019-2026
11. Europe Neglected Tropical Disease (NTD) Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Application
11.4.1. Hospitals and Clinics
11.4.2. Diagnostic Centers
11.4.3. Academic and Research Organizations
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Type
11.7.1. Drugs
11.7.2. Vaccines
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Neglected Tropical Disease (NTD) Treatment Demand Share, 2019-2026
12. Asia Pacific Neglected Tropical Disease (NTD) Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Application
12.4.1. Hospitals and Clinics
12.4.2. Diagnostic Centers
12.4.3. Academic and Research Organizations
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Type
12.7.1. Drugs
12.7.2. Vaccines
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Neglected Tropical Disease (NTD) Treatment Demand Share, 2019-2026
13. Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Application
13.4.1. Hospitals and Clinics
13.4.2. Diagnostic Centers
13.4.3. Academic and Research Organizations
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size and Volume Forecast by Type
13.7.1. Drugs
13.7.2. Vaccines
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Neglected Tropical Disease (NTD) Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Neglected Tropical Disease (NTD) Treatment Market: Market Share Analysis
14.2. Neglected Tropical Disease (NTD) Treatment Distributors and Customers
14.3. Neglected Tropical Disease (NTD) Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. F. Hoffmann-La Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bayer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GlaxoSmithKline
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Novartis
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Pfizer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Eisai
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sanofi
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Astellas Pharma
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Takeda Pharmaceutical Company
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Gilead Sciences
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
